SRZN
SRZN
NASDAQ · Biotechnology

Surrozen Inc

$29.64
+0.10 (+0.34%)
As of Sep 28, 10:15 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -73.2% upside
Low Target $5.53
Average Target $7.94
High Target $9.87
Current Price $29.64
Current
$29.64
Target
$7.94
$5.53 $7.94 avg $9.87
Scenario Analysis
Bear Case
$5.53
-81.3%
Low target
Base Case
$7.94
-73.2%
Avg target
Bull Case
$9.87
+-66.7%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$35.86
-17.3% from high
52-Week Low
$11.39
+160.2% from low
Target vs 52W High
$7.94
-77.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%